SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

A breakout to fresh 52-week highs has drawn attention, with traders citing BRIUMVIs sales growth and the Q3 results and subcutaneous Phase 3 data as key business catalysts. Buyout speculationparticularly involving Sanofiand hopes for short covering are widespread, but no deal is confirmed; some investors argue that execution matters more than takeover chatter.

Crown Castle, Inc. engages in the business of owning, operating, and leasing shared communications infrastructure. It operates through the following segments: Towers, Fiber, and Other. The Towers segment focuses on providing coverage and capacity for wireless carrier network deployments. The Fiber segment includes communications infrastructure offerings of small cells and fiber solutions. The Other segment is involved in corporate assets such as cash and cash equivalents. The company was founded by Ted B. Miller Jr. and Edward C. Hutcheson Jr. in 1994 and is headquartered in Houston, TX.

Crown Castle Inc

Crown Castle International Corp

Reports that SpaceX is discussing access to a large number of U.S. cell sites have focused attention on Crown Castle as traders weigh potential new tower-leasing demand for Starlink Mobile. Bulls see a hybrid satellite-and-terrestrial network as a boost for tower owners, while skeptics note that no agreement is signed and question execution, regulatory approval, and whether speculation has already driven the move.

Algorand (ALGO) is a cryptocurrency launched in 2019. Algorand has a current supply of 10,000,000,000 with 9,075,967,326.643147 in circulation. The last known price of Algorand is 0.09515711 USD and is down -0.23 over the last 24 hours. It is currently trading on 586 active market(s) with $49,581,617.87 traded over the last 24 hours. More information can be found at http://algorand.foundation.

Algorand

ALGO is drawing attention around a contested recovery thesis: bullish traders cite technical support, rebounds and a possible altcoin rotation, while bears point to persistent underperformance and the risk of further declines. Some bulls also highlight Algorands quantum-resistant technology and tokenization or payment use cases, though these are longer-term narratives rather than a confirmed near-term catalyst.

Chainlink (LINK) is a cryptocurrency launched in 2017and operates on the Ethereum platform. Chainlink has a current supply of 1,000,000,000 with 748,099,970.42488396 in circulation. The last known price of Chainlink is 11.67852871 USD and is up 2.18 over the last 24 hours. It is currently trading on 2313 active market(s) with $325,834,414.23 traded over the last 24 hours. More information can be found at https://chain.link/.

ChainLink

A volatile LINK rebound and repeated resistance tests are driving discussion, with bulls pointing to Chainlinks institutional and tokenization integrations, including its role in Coinbases Base tokenized-stock offering and CCIP 2.0. Skeptics warn that rallies have faded before and question whether network adoption will translate into value for the LINK token.

Bitdeer Technologies Group engages in the cryptocurrency mining industry. It generates income through its proprietary mining datacenters. The firm handles complex processes involved in computing such as equipment procurement, transport logistics, datacenter design and construction, equipment management, and daily operations. The company was founded by Wu Jihan in December 2021 and is headquartered in Singapore.

Bitdeer Technologies Group. - Ordinary Shares - Class A

Bitdeer Technologies Holding Co

BTDR is under pressure alongside Bitcoin miners and AI infrastructure stocks as traders cite Bitcoin weakness and a recent downgrade; some also blame short-selling, though that remains speculation. The community is split between calling the selloff an opportunity ahead of earnings and worrying the decline could continue, with many frustrated by BTDRs lagging performance versus peers.

Okta, Inc. engages in the provision of an identity management platform for enterprises. The firm operates through the following geographical segments: United States and International. Its products include single sign-on, multi-factor authentication, access gateway, API access management, authentication, adaptive MFA and lifecycle management. The company was founded by Todd McKinnon and J. Frederic Kerrest in 2009 and is headquartered in San Francisco, CA.

Okta Inc - Ordinary Shares - Class A

Okta Inc

Oktas upcoming addition to the S&P 500 is a major topic, with traders weighing expected index-fund buying against a possible sell-the-news move as the shares weaken. Some posts also cite an alleged DHS-related breach, but those claims are unverified in the discussion.

Northrop Grumman Corp. engages in the provision of advanced aircraft systems. It operates through the following segments: Aeronautics Systems, Defense Systems, Mission Systems, and Space Systems. The Aeronautics Systems segment is involved in the design, development, production, integration, sustainment, and modernization of advanced aircraft systems for the U.S. Air Force, the U.S. Navy, other U.S. government agencies, and international customers. The Defense Systems segment includes integrated battle management systems, weapons systems and aircraft, and mission systems sustainment and modernization. The Mission Systems segment offers advanced mission solutions and multifunction systems, primarily for the U.S. defense and intelligence community, and international customers. The Space Systems segment delivers end-to-end mission solutions through the design, development, integration, production and operation of space, missile defense, launch and strategic missile systems for national security, civil government, commercial, and international customers. The company was founded by John K. Northrop, Thomas V. Jones, and Kent Kresa in 1939 and is headquartered in Falls Church, VA.

Northrop Grumman Corp.

Northrop Grummans strong third-quarter results, higher full-year outlook and record backlog are driving discussion, with traders pointing to sustained defense demand. The reaction is mixed: some see the fundamentals as support for the shares, while others question the rally and expect a pullback.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

Amgen is drawing attention after dazodalibep met its Phase 3 endpoint in Sjgrens disease, with traders viewing the result as a pipeline catalyst. The discussion also cites strong IMDELLTRA/Imfinzi small-cell lung cancer data, alongside questions about whether recent momentum is already priced in.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

A newly disclosed performance-based option award for CEO Gregory Demopulos is drawing attention, with traders debating whether its stock-price and service conditions align his incentives with shareholders. The broader discussion remains focused on YARTEMLEAs U.S. sales growth and the next quarterly results, with bullish expectations balanced by caution after the European regulatory rejection.

Helus Pharma, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Helus Pharma is drawing attention ahead of expected Q4 topline results from its Phase 3 HLP003 trial for major depressive disorder, a pivotal catalyst for the clinical-stage biotech. Traders are optimistic about the treatments potential as an add-on to existing antidepressants, but debate the binary trial risk, possible dilution and how results could compare with peers.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Colgate Q3 Earnings Beat Estimates on Organic Sales & Pricing Gains

CL's Q3 earnings and sales beat estimates, fueled by organic growth, pricing gains and productivity efforts, prompting a higher 2026 profitability outlook.

Warby Parker to Announce Third Quarter 2026 Financial Results on November 5, 2026

Warby Parker Inc. (NYSE: WRBY) (the Company), a direct-to-consumer lifestyle brand focused on vision for all, today announced that its financial results for the third quarter ended September 30, 2026, will be released before market open on November 5, 2026. In addition, the Company will discuss its...

Warby Parker (WRBY) Surges 12.5%: Is This an Indication of Further Gains?

Warby Parker (WRBY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

These Stocks are Refusing to Cool Off

The closing bell is shaping up to be anything but quiet for these names that stand out as the session heads toward the finish. Greenland Energy Company (NASDAQ:GLND), NeOnc Technologies Holdings (NASDAQ:NTHI), GRAIL (NASDAQ:GRAL), Warby Parker (NYSE:WRBY), Montauk Renewables (NASDAQ:MNTK), Ginkgo Bioworks Holdings (NYSE:DNA), and CareDx (NASDAQ:CDNA).

Big Tech's Next AI Battleground Is Your Face, Loop Capital Says

Big Tech's Next AI Battleground Is Your Face, Loop Capital Says

 Smartglasses are set to be the "next major computing platform," according to Loop Capital analysts, as Meta currently leads the space, with Google, Samsung, Apple, and SNAP preparing their own AI-powered eyewear.

Loop...

Warby Parker Announces Participation in the Goldman Sachs 33rd Annual Global Retailing Conference

Warby Parker Inc. (NYSE: WRBY) (the Company), a direct-to-consumer lifestyle brand focused on vision for all, today announced that the Company will be presenting at the Goldman Sachs 33rd Annual Global Retailing Conference on Tuesday, September 15, 2026, at 11:30 a.m. Eastern Time. The presentation...

Warby Parker Co-CEO Gilboa Sells 11,504 Shares for $278,000

Key PointsThe disposal of 11,504 shares was completed at $24.19 per share for a total transaction value of ~$278,000...

Warby Parker (WRBY) Q2 2026 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Warby Parker Q2 Earnings Call Highlights

Warby Parker Q2 Earnings Call Highlights...

Here's What Key Metrics Tell Us About Warby Parker (WRBY) Q2 Earnings

The headline numbers for Warby Parker (WRBY) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Warby Parker, Inc. is an online retailer of eyewear for men and women, which engages in the business of selling eyewear products and providing optical services directly to consumers through its retail stores and e-commerce platform. Its products include eyeglasses, sunglasses and contacts. The company was founded by Neil Blumenthal, Andrew Martin Hunt, Jeffrey J. Raider and David Gilboa on July 6, 2010 and is headquartered in New York, NY.

Warby Parker Inc - Ordinary Shares - Class A

WRBY Stock Slips: Wall Street, Retail Traders Not Impressed Enough With Google, Samsung Smart Glass Tie-Up

Equity

Bearish Sentiment

<ul class="summary-bullets"><li>Glasses will let consumers interact with Google Gemini through voice commands.</li><li>Users will be able to ask for directions, play music, take voice calls, and listen to notification summaries.</li><li>Pricing and detailed specifications are yet to be released.</li></ul>Warby Parker (<a href="https://stocktwits.com/symbol/WRBY">WRBY</a>) share price dropped 9% on Tuesday, but recovered after-hours to trade up 0.6% after the company announced a collaboration with Google and Samsung to create smart glasses, rivaling Meta and Ray-Ban.&nbsp;The lifestyle brand unveiled eyewear designed for all-day wear that integrates technology from Google and Samsung. The debut style combines Warby Parker’s design approach with Google’s AI capabilities and Samsung’s mobile technology."Glasses are the most personal technology we use, and are the very first thing people notice about you," said Dave Gilboa, Co-Founder and Co-CEO of Warby Parker. "As we integrate advanced technology into our products, we’re staying true to the principles that define great eyewear: beautiful design, precision optics, and exceptional comfort in frames built for all-day, everyday wear."The smart glass capabilities include the ability to request directions, stream music, handle voice calls, and hear summaries of incoming notifications. Users can also manage their schedule by adding calendar appointments and utilize Gemini for live translation services. Integrated camera technology allows the device to provide information about objects in the user's field of vision. Additionally, the glasses support photo and video capture via physical buttons or voice control, featuring an LED indicator to notify others when recording is in progress.“We have to raise the bar and design for privacy from the ground up,” Shahram Izadi, vice president and general manager of Android XR at Google, said in an interview with Bloomberg ahead of the design reveal.Google and Samsung plan to share more specifics around privacy safeguards over the coming months. Pricing and a specific release date for the glasses haven’t yet been revealed.<h2 class="st-heading-2">WRBY Analyst View&nbsp;</h2>Stifel kept a ‘Hold’ rating on Warby Parker after the company announced its first intelligent eyewear frame and confirmed a fall 2026 launch. "While firmer details around launch timing this fall are encouraging, we view the release as a non-event," the analyst told investors in a research note.&nbsp;BTIG analyst Janine Stichter maintained a ‘Buy’ rating on Warby Parker. Stichter believes investors may be disappointed that details like concrete timing, hardware specs, including battery life and weight, and pricing were not released.&nbsp;In addition, investors "are eagerly waiting for the full 'display' model, while only the audio version is set for '26,” Stichter added.&nbsp;<h2 class="st-heading-2">WRBY Retail View&nbsp;</h2>One user thought the glasses looked “ugly” and was expecting the collaboration with Apple instead of Google.&nbsp;<stembedurl>https://stocktwits.com/oghowie/message/653841842</stembedurl>Another user felt that partnering with Google was bad for the&nbsp;firm’s bottom line.<stembedurl>https://stocktwits.com/CrispDry/message/653844613</stembedurl>The stock has gained about 45% over the past 12 months.Read More: <a href="https://stocktwits.com/news-articles/markets/equity/s-and-p-500-nasdaq-and-dow-end-lower-as-soaring-treasury-yields-reflect-inflation-concerns-googl-csco-hd-cost-wmt-in-focus/cZXHcLBReNo">S&amp;P 500, Nasdaq and Dow End Lower As Soaring Treasury Yields Reflect Inflation Concerns — GOOGL, CSCO, HD, COST, WMT In Focus</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A Warby Parker signage is seen at a store on May 22, 2024 in Downtown Brooklyn in New York City. (Photo by Michael M. Santiago/Getty Images)

Warby Parker (WRBY) share price dropped 9% on Tuesday, but recovered after-hours to trade up 0.6% after the company announced a collaboration with Google and Samsung to create smart glasses, rivaling Meta and Ray-Ban.&nbsp;

Samsung Electronics Co. and Alphabet Inc.’s Google unveiled the designs of smart glasses co-developed with eyewear partners Warby Parker and Gentle Monster. 

Alphabet Inc Class A

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Stocktwits

Stocktwits Polls

$WRBY Ascending trigangle pretty clean here. Either waiting for tighter consolidation below resistance or the breakout for a potential trade set up

Trader Ty

$WRBY I don't know why my post isn't showing. Android Authority has published that Google/Warby glasses will be released in November. I tried posting the link several times and I still don't see it.

Michael Bevans

$WRBY now that there is certainty about Nov launch, my guess is early Nov so sales can ramp up into Black Friday

Feed

News

Sentiment

Earnings

Fundamentals

Info

WRBY Warby Parker Inc - Ordinary Shares - Class A

Fundamentals

Latest WRBY News